SCHEMBL31542313

SCHEMBL31542313

Cc1cc2c(N3CCN(C)c4ccc(C#N)cc43)cc(C3CCN(CC4CCN(c5ccc(NC6CCC(=O)NC6=O)cc5F)CC4)CC3)cc2n(C)c1=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 9/20 0.33
▸ DDB1 Q16531 8/20 0.33
▸ ADRA1D P25100 1/20 0.31
▸ ADRA1A P35348 1/20 0.31
▸ ADRA1B P35368 1/20 0.31
▸ IKZF3 Q9UKT9 1/20 0.31
▸ CHRM4 P08173 1/20 0.31
▸ IKZF2 Q9UKS7 1/20 0.31
▸ ALK Q9UM73 2/20 0.31
▸ EGFR P00533 1/20 0.31
▸ RET P07949 1/20 0.31
▸ IGF1R P08069 1/20 0.31
▸ PDGFRB P09619 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ PDGFRA P16234 1/20 0.31
▸ FLT1 P17948 1/20 0.31
▸ LTK P29376 1/20 0.31
▸ AXL P30530 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ FLT3 P36888 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542230 0.97 CRBN (0.33) CRBNDDB1ADRA1DADRA1AADRA1B
SCHEMBL31542250 0.97 DDB1 (0.32) CRBNDDB1CHRM4ALKCYP3A4
SCHEMBL31542200 0.95 MEN1 (0.35) CRBNDDB1ADRA1DADRA1AADRA1B
SCHEMBL31542236 0.95 CHRM4 (0.33) CRBNDDB1ADRA1DADRA1AADRA1B
SCHEMBL31542240 0.95 DDB1 (0.34) CRBNDDB1IKZF2ALKEGFR
SCHEMBL31542195 0.95 CRBN (0.36) CRBNDDB1ADRA1DADRA1AADRA1B
SCHEMBL31542231 0.94 IKZF2 (0.31) CRBNDDB1IKZF2ALKEGFR
SCHEMBL31542182 0.94 CRBN (0.35) CRBNDDB1IKZF2ALKEGFR
SCHEMBL31542227 0.94 ALK (0.31) CRBNDDB1ADRA1DADRA1AADRA1B
SCHEMBL31542201 0.94 DDB1 (0.33) CRBNDDB1IKZF2ALKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025062330-A1 HETEROCYCLIC COMPOUNDS AS CBP SELECTIVE DEGRADERS AURIGENE ONCOLOGY LIMITED (IN) 2025-03-27 — — WO disclosed
Send feedback